Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Current Taxes (2023 - 2025)

Updated

Genmab A's Current Taxes was $43 million in the quarter ended Dec 31, 2025, down 82.0% from $239 million a year earlier.

Analysis

Genmab A (GMAB) Current Taxes (2023 - 2025) Analysis & Trends

From the quarter ended Sep 30, 2023 onward, Genmab A has reported Current Taxes for 7 quarters.

  • In earlier years, Current Taxes was $239 million in the year ended Dec 31, 2024, $8 million in the year ended Dec 31, 2023 and -$211 million in the year ended Dec 31, 2022.
  • Quarterly Current Taxes has moved between -$981 million (the quarter ended Sep 30, 2023) and $239 million (the quarter ended Dec 31, 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 1.98 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 4.31 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 1.47 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 438.00 Mn
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 43.00 Mn
Sep 30, 2025 -217.00 Mn
Jun 30, 2025 40.00 Mn
Mar 31, 2025 -49.00 Mn
Dec 31, 2024 239.00 Mn
Sep 30, 2024 -228.00 Mn
Mar 31, 2024 -57.00 Mn
Dec 31, 2023 8.00 Mn
Sep 30, 2023 -981.00 Mn
API Access

Genmab A Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=GMAB&period=max&api_key=YOUR_API_KEY